Difference between revisions of "Negative for intraepithelial lesion or malignancy"

From Libre Pathology
Jump to navigation Jump to search
(create)
 
(more)
Line 3: Line 3:
*No [[SIL]] is present.
*No [[SIL]] is present.
*No malignancy is present.
*No malignancy is present.
NILM does not exclude the presence of other findings, e.g. [[candida]].<ref>{{Cite journal  | last1 = Moriarty | first1 = AT. | last2 = Darragh | first2 = TM. | last3 = Fatheree | first3 = LA. | last4 = Souers | first4 = R. | last5 = Wilbur | first5 = DC. | title = Performance of Candida--fungal-induced atypia and proficiency testing: observations from the College of American Pathologists proficiency testing program. | journal = Arch Pathol Lab Med | volume = 133 | issue = 8 | pages = 1272-5 | month = Aug | year = 2009 | doi = 10.1043/1543-2165-133.8.1272 | PMID = 19653724 }}</ref>
==See also==
*[[Gynecologic cytopathology]].


==References==
==References==
{{Reflist|1}}
{{Reflist|2}}


[[Category:Gynecologic pathology]]
[[Category:Gynecologic pathology]]

Revision as of 02:42, 24 November 2013

Negative for intraepithelial lesion or malignancy, abbreviated NILM,[1] is the common terminology for - both of the following:

  • No SIL is present.
  • No malignancy is present.

NILM does not exclude the presence of other findings, e.g. candida.[2]

See also

References

  1. Sturgis, CD.; Schaaf, MR.; Tickman, RJ. (May 2013). "Focused rescreening of NILM Pap slides from women ≥ 30 years of age with positive high risk HPV DNA: an enhanced quality control measure.". Diagn Cytopathol 41 (5): 399-403. doi:10.1002/dc.22829. PMID 22351303.
  2. Moriarty, AT.; Darragh, TM.; Fatheree, LA.; Souers, R.; Wilbur, DC. (Aug 2009). "Performance of Candida--fungal-induced atypia and proficiency testing: observations from the College of American Pathologists proficiency testing program.". Arch Pathol Lab Med 133 (8): 1272-5. doi:10.1043/1543-2165-133.8.1272. PMID 19653724.